Antisense - ATL-1102

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Antisense - ATL-1102

Postby bromley » Wed Feb 13, 2008 1:08 am

Not much info - Teva is partnering with Antisense Therapeutics to help the latter get its MS drug - ATL-1102 - (currently Phase II) to market. ATL-1102 has a similar approach as Tysabri.

This is the second story within a month of a large drugs company partnering with a smaller one (other one was BioMS and Lilly).

Probably shows that these drugs show some promise.

Ian

http://c.moreover.com/click/here.pl?j12 ... 5&w=464753
User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Postby bromley » Wed Feb 13, 2008 2:57 am

A bit more on the partnering arrangement (see news on right hand side).

Phase IIa results are expected in mid 2008.

http://www.antisense.com.au/!upload_fil ... 20Teva.pdf
User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service